Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kolb

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1983
Treatment of familial hypercholesterolemia by portacaval anastomosis: effect on cholesterol metabolism and pool sizesD J McNamara, E H Ahrens, R Kolb, et al.
Neuropediatrics|March 6, 2004
CNS disease as the main manifestation of hemophagocytic lymphohistiocytosis in two childrenK Rostasy, R Kolb, D Pohl, et al.
Wiener Klinische Wochenschrift|November 21, 1980
[Oestrogen receptors and prognosis in breast cancer]H Rainer, P Bettelheim, C Bieglmayer, et al.
Acta Medica Austriaca. Supplement|January 1, 1979
[Prognostic factors in the drug therapy of metastasizing breast cancer]R Mörz, M Schemper, P Bettelheim, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients. Austrian Breast Cancer Study GroupR Jakesz, H Samonigg, M Gnant, et al.
The Journal of Clinical Investigation|September 1, 1984
Plasma mevalonate as a measure of cholesterol synthesis in manT S Parker, D J McNamara, C D Brown, et al.
Biomaterials|September 9, 2024
Modulating pro-fibrotic macrophages using yeast beta-glucan microparticles prepared by Pressurized Gas eXpanded liquid (PGX) Technology®S Naiel, N Dowdall, Q Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancerR Jakesz, H Hausmaninger, K Haider, et al.
Onkologie|May 29, 2003
Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patientsF Ploner, R Jakesz, H Hausmaninger, et al.
Pulmonary Pharmacology & Therapeutics|August 5, 2020
Inhalation: A means to explore and optimize nintedanib's pharmacokinetic/pharmacodynamic relationshipGali Epstein-Shochet, Stephen Pham, Steven Beck, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1983
Treatment of familial hypercholesterolemia by portacaval anastomosis: effect on cholesterol metabolism and pool sizesD J McNamara, E H Ahrens, R Kolb, et al.
Neuropediatrics|March 6, 2004
CNS disease as the main manifestation of hemophagocytic lymphohistiocytosis in two childrenK Rostasy, R Kolb, D Pohl, et al.
Wiener Klinische Wochenschrift|November 21, 1980
[Oestrogen receptors and prognosis in breast cancer]H Rainer, P Bettelheim, C Bieglmayer, et al.
Acta Medica Austriaca. Supplement|January 1, 1979
[Prognostic factors in the drug therapy of metastasizing breast cancer]R Mörz, M Schemper, P Bettelheim, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients. Austrian Breast Cancer Study GroupR Jakesz, H Samonigg, M Gnant, et al.
The Journal of Clinical Investigation|September 1, 1984
Plasma mevalonate as a measure of cholesterol synthesis in manT S Parker, D J McNamara, C D Brown, et al.
Biomaterials|September 9, 2024
Modulating pro-fibrotic macrophages using yeast beta-glucan microparticles prepared by Pressurized Gas eXpanded liquid (PGX) Technology®S Naiel, N Dowdall, Q Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancerR Jakesz, H Hausmaninger, K Haider, et al.
Onkologie|May 29, 2003
Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patientsF Ploner, R Jakesz, H Hausmaninger, et al.
Pulmonary Pharmacology & Therapeutics|August 5, 2020
Inhalation: A means to explore and optimize nintedanib's pharmacokinetic/pharmacodynamic relationshipGali Epstein-Shochet, Stephen Pham, Steven Beck, et al.
Pageof 12